sur CEGEDIM (EPA:CGM)
Strategic partnership between Cegedim and PHAST to improve the traceability of medical devices
Cegedim Business Services and PHAST announce a partnership aimed at strengthening the traceability of implantable medical devices (IMDs) in hospitals. This partnership is part of the regulatory challenges related to the management of IMDs in healthcare institutions. Sedistock, Cegedim's solution, will use the CIOdm interoperability catalog to ensure better interoperability between applications in the IMD circuit.
This partnership promises to streamline information exchanges, thus meeting the growing requirements in terms of traceability. Care teams will benefit from time savings and data optimization. Sedistock and CIOdm customers will see their traceability processes simplified. The solution also helps to monitor reimbursement indications for medical devices.
The two companies will present their collaboration at the Euro-Pharmat trade fair in Lille.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de CEGEDIM